Biotechnology Value Trading Fund OS LP

• Director at CELL THERAPEUTICS INC · on record since Jun 28, 2023
• Director at Olema Pharmaceuticals, Inc. · on record since Jun 21, 2023
• See explanation of responses at Structure Therapeutics Inc. · on record since Feb 13, 2023
• See Explanation of Responses at enGene Holdings Inc. · on record since Nov 13, 2023
• See Explanation of Responses at Therapeutics Acquisition Corp. · on record since Nov 6, 2023
• Director at Rain Enhancement Technologies Holdco, Inc. · on record since Jan 29, 2024
• See Remarks; Former 10% Owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 27, 2021
• See Explanation of Responses at Allakos Inc. · on record since Jan 26, 2024
• See Explanation of Responses at Xenon Pharmaceuticals Inc. · on record since Sep 12, 2016
• Director at IMMUNIC, INC. · on record since Feb 27, 2026
• See Explanation of Responses at IMMUNIC, INC. · on record since Feb 27, 2026
• Director at MoonLake Immunotherapeutics · on record since Apr 2, 2026
• See Explanation of Responses at MoonLake Immunotherapeutics · on record since Apr 2, 2026
• 10% owner at DISCOVERY PARTNERS INTERNATIONAL INC · on record since Dec 30, 2016
• See Explanation of Responses at XOMA LTD /DE/ · on record since May 18, 2026
• See Explanation of Responses at Oncothyreon Inc. · on record since Dec 22, 2015
• 10% owner at Oncothyreon Inc. · on record since Jun 27, 2016
• See Explanation of Responses at DISCOVERY PARTNERS INTERNATIONAL INC · on record since Dec 2, 2016
• See Explanation of Responses at NOVELLUS SYSTEMS INC · on record since Jun 22, 2017
• See Explanation of Responses at CELL THERAPEUTICS INC · on record since Jun 14, 2017
• See Explanation of Responses at GLYCOMIMETICS INC · on record since May 11, 2017
• See Explanation of Responses at CONCERT PHARMACEUTICALS, INC. · on record since Sep 29, 2017
• See Explanation of Responses at Regulus Therapeutics Inc. · on record since Nov 27, 2017
• See Explanation of Responses at ARQULE INC · on record since Oct 20, 2017
• See Explanation of Responses at Syndax Pharmaceuticals Inc · on record since Dec 8, 2017
• See Explanation of Responses at PALVELLA THERAPEUTICS, INC. · on record since Nov 26, 2018
• See Explanation of Responses at Immune Design Corp. · on record since Nov 9, 2018
• See Explanation of Responses at Calithera Biosciences, Inc. · on record since Jul 1, 2019
• See Explanation of Responses at FIVE PRIME THERAPEUTICS INC · on record since Oct 31, 2019
• See Explanation of Responses at CYTOKINETICS INC · on record since Dec 12, 2019
• See Explanation of Responses at Merus N.V. · on record since Jan 21, 2020
• See Explanation of Responses at IDEAYA Biosciences, Inc. · on record since Jun 22, 2020
• See Explanation of Responses at Principia Biopharma Inc. · on record since Aug 20, 2020
• See Explanation of Responses at Tokai Pharmaceuticals Inc · on record since Dec 28, 2020
• See Explanation of Responses at CytomX Therapeutics, Inc. · on record since Dec 28, 2020
• See Explanation of Responses at Olema Pharmaceuticals, Inc. · on record since Nov 20, 2020
• See Explanation of Responses at Repare Therapeutics Inc. · on record since Nov 8, 2021
• See Explanation of Responses at Cullinan Therapeutics, Inc. · on record since Jan 10, 2022
• See Explanation of Responses at Verastem, Inc. · on record since Feb 7, 2022
• See Explanation of Responses at 4D Molecular Therapeutics, Inc. · on record since Jun 27, 2022
• See Explanation of Responses at EPIX Pharmaceuticals, Inc. · on record since Jul 21, 2022
• See Explanation of Responses at TF FINANCIAL CORP · on record since Dec 22, 2022
• Director at Kymera Therapeutics, Inc. · on record since Jan 13, 2023
• See Remarks and Footnotes at Kymera Therapeutics, Inc. · on record since Aug 25, 2020
• Director at XOMA LTD /DE/ · on record since Jan 9, 2023